Valuation: KPC Pharmaceuticals,Inc.

Market Cap 6.52B 978M 877M 811M 734M 1.37B 93.1B 1.39B 9.7B 3.86B 48.72B 3.67B 3.59B 155B P/E 2026 *
199x
P/E 2027 * 25.8x
Enterprise Value 6.52B 978M 877M 811M 734M 1.37B 93.1B 1.39B 9.7B 3.86B 48.72B 3.67B 3.59B 155B EV / Sales 2026 *
1.24x
EV / Sales 2027 * 1.13x
Free-Float
61.63%
Yield 2026 *
-
Yield 2027 * -
1 day-0.12%
1 week-1.03%
Current month+6.17%
1 month+7.22%
3 months-5.49%
6 months-9.27%
Current year-31.45%
1 week 8.55
Extreme 8.55
9
1 month 7.97
Extreme 7.97
9.24
Current year 7.45
Extreme 7.45
13.55
1 year 7.45
Extreme 7.45
14.05
3 years 7.45
Extreme 7.45
24.11
5 years 7.45
Extreme 7.45
26.09
10 years 5.95
Extreme 5.95
26.09
Manager TitleAgeSince
Director of Finance/CFO - 03/01/2023
President 51 05/01/2026
Investor Relations Contact 37 -
Director TitleAgeSince
Director/Board Member - -
Director/Board Member 64 01/11/2009
Director/Board Member 66 08/12/2021
Change 5-day change 1-year change 3-year change Capi.($)
-0.12%-1.03%-36.64%-56.54% 978M
+0.50%+1.38%+57.09%+129.96% 1,148B
+0.86%+5.14%+45.00%+86.15% 652B
-0.14%+0.42%+25.69%+105.85% 505B
+0.39%+2.32%+54.07%+66.27% 384B
-0.63%-5.97%+61.93%+37.06% 348B
+2.18%+2.48%+34.09%+56.07% 294B
+0.89%-0.66%+2.66%+26.19% 264B
+0.87%+3.08%+54.69%+72.74% 244B
+0.08%+3.67%+35.05%+107.78% 197B
Average +0.48%+1.14%+33.36%+63.15% 403.81B
Weighted average by Cap. +0.52%+1.50%+44.86%+89.06%

Financials

2026 *2027 *
Net sales 5.24B 786M 705M 652M 590M 1.1B 74.82B 1.12B 7.79B 3.1B 39.15B 2.95B 2.89B 124B 5.77B 865M 776M 718M 650M 1.21B 82.38B 1.23B 8.58B 3.42B 43.11B 3.25B 3.18B 137B
Net income 35.27M 5.29M 4.75M 4.39M 3.97M 7.42M 504M 7.51M 52.46M 20.9M 264M 19.85M 19.43M 837M 250M 37.47M 33.61M 31.08M 28.15M 52.59M 3.57B 53.22M 372M 148M 1.87B 141M 138M 5.93B
Net Debt - -
Projected Income Statement - Annual - KPC Pharmaceuticals,Inc.
Logo KPC Pharmaceuticals,Inc.
KPC Pharmaceuticals Inc is a China-based company primarily engaged in the research, development, manufacturing and sales of pharmaceuticals. The Company operates mainly through two segments. The Pharmaceutical segment focuses on the research and development and manufacturing of drugs for cardiovascular and cerebrovascular treatments, orthopedics, antimalarial drugs, gynecological drugs and digestive system drugs. The Pharmaceutical Wholesale segment is primarily engaged in the wholesale and retail of pharmaceuticals and medical devices. The Company conducts business in both domestic and overseas markets.
Employees
5,072
Date Price Change Volume
28/10/26 CN¥8.610 -0.12% 8,051,499
27/10/26 CN¥8.620 -3.69% 10,467,900
26/10/26 CN¥8.950 +1.59% 9,923,599
23/10/26 CN¥8.810 +1.26% 11,511,675
22/10/26 CN¥8.700 0.00% 8,533,029
Trader
Investor
Global
Quality
ESG MSCI
-
MarketScreener Ratings - KPC Pharmaceuticals,Inc.
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
8.610CNY
Average target price
13.82CNY
Spread / Average Target
+60.51%

Annual profits - Rate of surprise

Rate of surprise - EPS - Annual - KPC Pharmaceuticals,Inc.
  1. Stock Market
  2. Stocks
  3. 600422 Stock